NEW YORK CITY, NY / ACCESS Newswire / June 23, 2025 / Sun Communities, Inc. (NYSE: SUI)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose material information. Specifically, the Company provided investors with material information concerning SUI's accounting practices and internal control over financial reporting. Allegedly, the Company provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning where money was coming from, namely, undisclosed loans and a $4 million mortgage.
On September 24, 2024, after market close, Blue Orca Capital published a report that the Company's CEO received an undisclosed $4 million mortgage from the family of a Company Board member. In addition, the report found that the CEO borrowed money from another Board member. Blue Orca's investigation concluded that the CEO and his undisclosed loans from purported independent Board members greatly "compromises the independence of the Board as a whole, the Compensation Committee and, critically, the Audit Committee." It also raises "questions as to the integrity of the Company's governance, controls and financial disclosures." Following the report's revelations, the Company's stock price declined dramatically.
If you are a SUI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Pacira Biosciences, Inc. (NASDAQ: PCRX)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose material information. Specifically, Pacira allegedly disseminated materially false and misleading statements and/or concealed material adverse facts concerning the validity and scope of the Company's patents. On August 9, 2024, Pacira announced that the New Jersey District Court had invalidated its ‘495 patent. This announcement surprised investors and analysts alike as they reacted immediately to the revelations, and the price of Pacira's common stock declined dramatically.
If you are a PCRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ModivCare, Inc. (NASDAQ: MODV)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose to investors material information. Specifically, certain contracts that the Company used in its non-emergency medical transportation ("NEMT") segment allegedly caused the Company's free cash flow to deteriorate and as a result, (i) contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA; (ii) the Company had insufficient liquidity; and (iii) the Company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you are a MODV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Integral Ad Science Holding Corp. (NASDAQ: IAS)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose material information. Specifically, the Company allegedly misrepresented and/or failed to disclose (1) that IAS was experiencing a new material trend of increased competitive pricing pressures and that, as a result, IAS had been forced to cut prices to compensate for weakening demand and slowing revenue growth; (2) that IAS's pricing function was no longer "favorable" and IAS could not sustain its pricing and drive price increases; (3) that pricing had become a key differentiator between IAS and its competitor necessary to close major renewals and new deals; (4) that the risk that competition "could result in increased pricing pressure" or "could put pressure on us to change our prices" had in fact transpired; and (5) as a result, the Company's public statements were materially false and misleading.
If you are an IAS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ATTORNEY ADVERTISING.© 2025 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: jlifshitz@lifshitzlaw.com
SOURCE: Lifshitz Law Firm
View the original press release on ACCESS Newswire
